This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Aucentra Therapeutics Pty Ltd. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- South Australia, AU (2019)
- Adelaide, AU (2024)
Company Filing History:
Years Active: 2019-2024
Title: Solomon Tadesse Zeleke: Innovator in Therapeutic Compounds
Introduction
Solomon Tadesse Zeleke is a prominent inventor based in Adelaide, Australia. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors for protein kinases. His work is crucial in addressing various cell proliferative diseases, including certain types of cancer.
Latest Patents
Solomon holds 3 patents that focus on N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives. These compounds serve as a novel class of inhibitors that target protein kinases, which are essential in the treatment of diseases characterized by the over-expression of CDK4, CDK6, and/or cyclin D. His latest patents highlight their potential in treating cancers of the lung, breast, brain, central nervous system, colorectal cancer, and leukaemias.
Career Highlights
Solomon is currently associated with Aucentra Therapeutics Pty Ltd, where he continues to innovate in the field of therapeutic research. His expertise and dedication have positioned him as a key figure in the development of new treatment options for serious health conditions.
Collaborations
He has collaborated with notable colleagues such as Shudong Wang and Mingfeng Yu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Solomon Tadesse Zeleke's work in developing therapeutic compounds showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his significant impact on the field of cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile